SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-028702
Filing Date
2021-08-18
Accepted
2021-08-17 17:34:27
Documents
15
Period of Report
2021-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10028155_8k.htm   iXBRL 8-K 34348
2 EXHIBIT 99.1 brhc10028155_ex99-1.htm EX-99.1 42498
6 image00002.jpg GRAPHIC 3633
7 image00003.jpg GRAPHIC 4169
  Complete submission text file 0001140361-21-028702.txt   240413

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210817.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210817_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210817_pre.xml EX-101.PRE 16038
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028155_8k_htm.xml XML 4393
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 211184217
SIC: 2833 Medicinal Chemicals & Botanical Products